— Know what they know.
Not Investment Advice

CAI NASDAQ

Caris Life Sciences, Inc.
1W: +6.9% 1M: -24.6% 3M: -24.7% YTD: -41.8%
$15.70
+0.74 (+4.95%)
 
Weekly Expected Move ±13.3%
$11 $13 $15 $16 $18
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 37 · $4.4B mcap · 11M float · 23.58% daily turnover · Short 46% of daily vol
Smart Money Score
Moderate 50
Insider+$0.5M
Congress
ETF Holdings
Key Statistics
Market Cap$4.4B
52W Range14.19-42.5
Volume2,713,055
Avg Volume2,663,431
Beta1.09
Dividend
Analyst Ratings
6 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEODavid Dean Halbert
Employees1,769
SectorHealthcare
IndustryBiotechnology
IPO Date2025-06-18
750 West John Carpenter Freeway
Irving, TX 75039
US
866 771 8946
About Caris Life Sciences, Inc.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Recent Insider Trades

NameTypeSharesPriceDate
Denton John Russel F-InKind 6,047 $15.25 2026-05-15
Power Luke Thomas F-InKind 9,771 $15.25 2026-05-15
Spetzler David Baxle F-InKind 13,856 $15.25 2026-05-15
Brille Brian J F-InKind 13,987 $15.25 2026-05-15
HALBERT DAVID D F-InKind 40,712 $15.25 2026-05-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms